Sign in

CIK 0001781174 · <br>Emerging growth company

Acrivon Therapeutics, Inc.

Sign in to watch
Ticker
ACRV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
825125532
Phone
617-207-8979
Business address
480 ARSENAL WAY, SUITE 100, WATERTOWN, MA, 02472
  1. 4 Grant or award Director acquired 9,366 shares (grant or award)
  2. 4 Grant or award Director acquired 9,366 shares (grant or award)
  3. 4 Grant or award Director acquired 9,366 shares (grant or award)
  4. 4 Grant or award Director acquired 9,366 shares (grant or award)
  5. 4 Grant or award Director acquired 9,366 shares (grant or award)
  6. 4 Grant or award Director acquired 9,366 shares (grant or award)
  7. 4 Grant or award Director acquired 9,366 shares (grant or award)
  8. 4 Grant or award Chief Accounting Officer acquired 14,227 shares (grant or award)
  9. 4 Grant or award Chief Medical Officer acquired 38,817 shares (grant or award)
  10. 4 Grant or award Chief Legal Officer acquired 49,830 shares (grant or award)
  11. 4 Grant or award Chief Financial Officer acquired 46,167 shares (grant or award)
  12. 4 Grant or award Chief Development Officer acquired 38,584 shares (grant or award)
  13. 4 Grant or award Chief Operating Officer acquired 72,981 shares (grant or award)
  14. 4 Grant or award President and CEO acquired 252,801 shares (grant or award)
  15. 4 Shares withheld for taxes Chief Accounting Officer gave up 99 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Legal Officer gave up 184 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Development Officer gave up 404 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Operating Officer gave up 613 shares (to pay taxes)
  19. 4 Shares withheld for taxes President and CEO gave up 1,743 shares (to pay taxes)
  20. 4 Grant or award Director acquired 3,888,888 shares (grant or award)

Page 2 of 11 · 206 filings